The resistance microorganisms are developing in the last decade worldwide, and Indonesia is not the exception. The surveillance of antimicrobial resistance (AMR) in 2013, among hospitals in Indonesia, the prevalence rate of ESBL producing bacteria were range 30% until 70%.  The prevalence of MRSA (Methicillin Resistance Staphylococcus aureus) increase from less than 1% to above 5% in recent 15 years. It will impact on infection management in hospital setting. The role of clinical Microbiologist directly joint together with clinicians in ward, will have a synergistic outcome for all stakeholders.

The Programme of Containment of AMR nationwide has been planned by Ministry of Health (MoH) Republic of Indonesia, since the first establishment of KPRA (National Board for AMR Containment Programme).  Implementation of this programme should be conducted  through integration of all stake-holders in Infection management, mainly the Clinicians and Clinical Microbiologist. All the above activities will fruitfull and benefecial for all people, health management, and health provider, mainly the National Insurance Company, in the era of total coverage of health insurance.

All these issues will be persented, discussed and issued in the forum of Annual Scientific Meeting (ASM)/Pertemuan Ilimiah Tahunan (PIT) of Perhimpunan Ahli Mikrobiologi Klinik Indonesia (PAMKI) 2016 in Solo, Central Java, work together with Department of Microbiology, Faculty of Medicine, Sebelas Maret University and RS. Dr. Moewardi Hospital, Solo, Central Java.The meeting  will be held in Sunan Hotel on Friday-Sunday/September 9th -11st, 2016 with the theme of "Collaboration Between Clinician and Clinical Microbiologists for Strengthening the Control and Preventing the Antimicrobial Resistance."

The ASM Solo 2016 will be conducted in symposia, course, plenary lecture and discussion. It will convene renowned speakers from clinicians, microbiologist, and all linked disciplines, from both of Indonesian and abroad. Some recent development and research results will be incorporated in these symposia. The pro-con debates on area of infection control and management will be also scheduled.

We hope this symposium will produce recommendations on efforts to reduce the emergence and spread of antimicrobial-resistant micro organisms. It is indeed my honor to invite you to attend, participate and support the symposium, so that the goal of controlling antimicrobial resistance could be well achieved.

Solo, November 23th, 2016

On behalf of the Chairman of
Indonesian Association for Clinical Microbiology (PAMKI)